Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Cronos Australia Ltd. ( (AU:VIT) ) has shared an update.
Vitura Health Limited reported positive business momentum in Q3 FY2025, aligning with its Strategic Reset goals. The company saw successive revenue and EBITDA growth, driven by the integration of Candor Medical and Releaf Group, expansion of its Canview platform, and operational efficiencies. Despite slightly missing its annual revenue growth target, Vitura anticipates meeting its EBITDA margin and OPEX efficiency goals, setting a strong foundation for FY2026.
More about Cronos Australia Ltd.
Vitura Health Limited is a leading digital health platform business in Australia, focusing on traditional and emerging therapies. The company is involved in integrating acquired businesses to enhance revenue and EBITDA, while expanding its Canview platform and maintaining cost control.
Average Trading Volume: 497,298
Technical Sentiment Signal: Sell
Current Market Cap: A$47.68M
For a thorough assessment of VIT stock, go to TipRanks’ Stock Analysis page.